文献速递甲状腺与浅表头颈US

超声弹性成像在甲状腺结节诊断中的评估:ElaTION随机对照试验

Evaluation of US Elastography in Thyroid Nodule Diagnosis: The ElaTION Randomized Control Trial.
PubMed 文献 · Radiology · 2024-01-01

ElaTION多中心随机对照试验纳入982例未行细针穿刺的甲状腺结节患者,比较超声弹性成像引导与常规超声引导细针穿刺细胞学检查。首次穿刺后Thy1无诊断率两组无差异(19% vs 16%;RD 0.03 [95%CI -0.01, 0.07];P=0.11),应变弹性成像对甲状腺结节恶性诊断未显示额外获益。

要点

  • 超声弹性成像引导穿刺未降低首次细针穿刺的Thy1无诊断率(19% vs 16%,P=0.11)。
  • 两组最终确诊中位时间无差异:弹性成像组3.3个月 vs 常规组3.4个月。
  • 两组恶性率无差异(14% vs 16%,P=0.39),应变弹性成像未见额外诊断获益。

核心结论

  • 应变超声弹性成像在甲状腺结节恶性诊断中似乎未较常规超声引导细针穿刺细胞学检查带来额外获益。

研究设计与样本

  • 在英格兰18家二级和三级医院开展的实用性多中心随机对照试验,2015年2月至2018年9月纳入982例未行细针穿刺的成人甲状腺结节患者,按1:1随机分为超声弹性成像引导细针穿刺组(干预)和常规超声引导细针穿刺组(对照)。

诊断标准与关键数值

  • 主要结局为首次细针穿刺后细胞学结果为无诊断性Thy1(英国甲状腺协会系统)的患者比例:弹性成像组19% vs 常规组16%,风险差0.03(95%CI -0.01, 0.07),P=0.11。

临床应用与阅片要点

  • 研究采用应变超声弹性成像(493例弹性成像组中467例[94.7%]接受应变弹性成像),主要结局和敏感性分析均未显示弹性成像引导穿刺较常规超声引导穿刺降低Thy1无诊断率。

局限性

  • 原文结论指出应变超声弹性成像似乎未较常规超声引导细针穿刺细胞学检查在甲状腺结节恶性诊断中带来额外获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background There is variable evidence and no randomized trials on the benefit of US elastography-guided fine-needle aspiration cytology (FNAC) over conventional US-guided FNAC alone for thyroid nodules. Purpose To compare the efficacy of US elastography-guided FNAC versus US-guided FNAC in reducing nondiagnostic rates for thyroid nodules. Materials and Methods A pragmatic, multicenter randomized controlled trial was performed at 18 secondary and tertiary hospitals across England between February 2015 and September 2018. Eligible adults with single or multiple thyroid nodules who had not previously undergone FNAC were randomized (1:1 ratio) to US elastography FNAC (intervention) or conventional US FNAC (control). The primary outcome was the proportion of patients who have a nondiagnostic cytologic Thy1 (British Thyroid Association system) result following the first FNAC. Results A total of 982 participants (mean age, 51.3 years ± 15 [SD] [IQR, 39-63]; male-to-female ratio, 1:4) were randomized. Of the 493 participants who underwent US elastography, 467 (94.7%) were examined with strain US elastography. There was no difference between the two arms in the nondiagnostic (Thy1) rate following the first FNAC (19% vs 16%; risk difference [RD], 0.03 [95% CI: -0.01, 0.07]; P = .11) or in the median time to reach the final definitive diagnosis (3.3 months [IQR, 1.5-6.4] for US elastography FNAC vs 3.4 months [IQR, 1.5-6.2] for US FNAC). All sensitivity analyses supported the primary analysis. Fewer participants in the US elastography FNAC arm underwent diagnostic hemithyroidectomy than in the US FNAC arm (183 of 493 [37%] vs 196 of 489 [40%]), but this was not statistically significant (adjusted RD, 0.02 [95% CI: -0.06, 0.01]; P = 0.15). There was no evidence of a difference in malignancy rates between the two arms: 70 of 493 (14%) in US elastography FNAC arm versus 79 of 489 (16%) in US FNAC arm (P = .39). There was also no difference in the rate of benign histologic findings between the groups (RD, -0.01 [95% CI: -0.04, 0.03]; P = .7). Conclusion Strain US elastography does not appear to have additional benefit over conventional US FNAC in the diagnosis of malignancy in thyroid nodules. Clinical trial registration no. ISRCTN18261857 Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Isikbay and Harwin in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Mehanna H, Sidhu PS, Madani G, et al. Evaluation of US Elastography in Thyroid Nodule Diagnosis: The ElaTION Randomized Control Trial. Radiology. 2024. PMID: 39404634. doi:10.1148/radiol.240705

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。